AMA Wisconsin State Medical Society: Dumping Gifts Thomas Sullivan Oct 20, 2008 2 This past week the Wisconsin Medical Society passed a voluntary ban on gifts to physicians becoming the first state medical…
Congress Letters from Kohl and Grassley: CRF and Columbia — Send us Everything Thomas Sullivan Oct 17, 2008 0 This has been a tremendous week of clinical trial presentations and discussions around interventional cardiology at the…
State Policy DC Safe RX = Unsafe RX Thomas Sullivan Oct 16, 2008 0 If you are planning your medical convention or meeting in the District of Columbia you may want to consider the following…
Physician Payment Sunshine Act Physician Payment Sunshine: MedPac Prepares to Act Thomas Sullivan Oct 13, 2008 0 MedPac, a congressional advisory group, has been holding a series of meetings the last three months to suggest to Congress…
Uncategorized Presidential Debate 2: Candidates from Mars Thomas Sullivan Oct 9, 2008 0 "What a funny title?!" you say, but from watching the presidential debate on Tuesday night between Barak Obama and John…
Pharmaceutical and Device Eli Lilly: Settles Down with State AG’s Thomas Sullivan Oct 8, 2008 1 Yesterday Eli Lilly settled a consumer protection lawsuit on Zyprexa, one of their psychiatric drugs, for $62 million with 32…
Congress Letters from Grassley: Emory Professor Caught with Hands in Cookie Jar Thomas Sullivan Oct 6, 2008 0 What started as a sleepy story about a physician who had failed to report conflict of interest to Emory University has led…
Congress Senator Grassley: Interview Provides Context Thomas Sullivan Oct 6, 2008 0 For those of us who have followed Senator’s Grassley’s interest in the pharmaceutical and device industry, there often…
Pharmaceutical and Device Physician Payment Sunshine: Cephalon Agreement to Act Thomas Sullivan Sep 30, 2008 1 Every industry has its bad actors. In the case of pharmaceutical companies the bad actors fall into two categories; those…
Pharmaceutical and Device Pfizer Cardiovascular: The End of an Era Thomas Sullivan Sep 30, 2008 0 Pfizer announced WSJ: Pfizer Plans to Abandon Heart-Drug Development that they are giving up on the Cardiovascular business…